- Previous Close
8.23 - Open
8.16 - Bid 8.21 x 40700
- Ask 8.23 x 40000
- Day's Range
8.16 - 8.23 - 52 Week Range
6.82 - 11.96 - Volume
79,747 - Avg. Volume
807,182 - Market Cap (intraday)
32.411B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
-- - EPS (TTM)
-0.36 - Earnings Date Nov 12, 2024
- Forward Dividend & Yield 0.03 (0.36%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
22.11
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
www.bayer.com96,567
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BAYRY
View MorePerformance Overview: BAYRY
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BAYRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BAYRY
View MoreValuation Measures
Market Cap
32.31B
Enterprise Value
67.94B
Trailing P/E
--
Forward P/E
5.52
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.62
Price/Book (mrq)
0.82
Enterprise Value/Revenue
1.31
Enterprise Value/EBITDA
6.32
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.69%
Return on Assets (ttm)
3.71%
Return on Equity (ttm)
-3.45%
Revenue (ttm)
47.11B
Net Income Avi to Common (ttm)
-1.27B
Diluted EPS (ttm)
-0.36
Balance Sheet and Cash Flow
Total Cash (mrq)
10.02B
Total Debt/Equity (mrq)
129.94%
Levered Free Cash Flow (ttm)
6.26B
Research Analysis: BAYRY
View MoreCompany Insights: BAYRY
BAYRY does not have Company Insights
Research Reports: BAYRY
View MoreBayer Earnings: Steady Growth Supported by New Drug Launches Offsetting Generic Pressures
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetBayer Earnings: Solid Results Aided by Litigation Win, Cost-Cutting, and Innovation Advancements
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetBayer Earnings: Expected Cost Pressures Lead to a Valuation Cut, but Stock Remains Undervalued
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice TargetBayer: Dividend Cut Increases Flexibility to Reduce Debt, Improve Operations, and Expand Innovation
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
RatingPrice Target